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ABSTRACT
MicroRNAs (miRNAs) are short noncoding RNAs,
which bind to messenger RNAs and regulate
protein expression. The biosynthesis of miRNAs
includes two precursors, a primary miRNA tran-
script (pri-miRNA) and a shorter pre-miRNA, both
of which carry a common stem-loop bearing the
mature miRNA. MiR-122 is a liver-specific miRNA
with an important role in the life cycle of hepatitis
C virus (HCV). It is the target of miravirsen
(SPC3649), an antimiR drug candidate currently in
clinical testing for treatment of HCV infections.
Miravirsen is composed of locked nucleic acid
(LNAs) ribonucleotides interspaced throughout a
DNA phosphorothioate sequence complementary
to mature miR-122. The LNA modifications endow
the drug with high affinity for its target and provide
resistance to nuclease degradation. While
miravirsen is thought to work mainly by hybridizing
to mature miR-122 and blocking its interaction with
HCV RNA, its target sequence is also present in pri-
and pre-miR-122. Using new in vitro and cellular
assays specifically developed to discover ligands
that suppress biogenesis of miR-122, we show
that miravirsen binds to the stem-loop structure of
pri- and pre-miR-122 with nanomolar affinity, and
inhibits both Dicer- and Drosha-mediated process-
ing of miR-122 precursors. This inhibition may
contribute to the pharmacological activity of the
drug in man.
INTRODUCTION
MicroRNAs (miRNAs) are the products of a multistep
biogenesis (1). Most primary miRNA transcripts (pri-
miRNA) are produced from Pol II-mediated transcrip-
tion. They are cleaved by the nuclear Microprocessor
complex to yield a pre-miRNA stem-loop with a short
overhang at its 30-terminus (2–4). The pre-miRNA is
transported to the cytoplasm where Dicer and its
partner proteins excise the loop, creating a double-
stranded RNA composed of mature miRNA strands
(5–7). Both arms of the stem may be functional and may
be used in a cell-context–dependent fashion (8,9). Mature
miRNAs are bound by Argonaute proteins and associated
factors to form the miRNA-induced silencing complex
(miRISC) (10). MiRISC is guided to target sites in the
30-untranslated regions (UTRs) of mRNAs where it
inhibits protein translation or induces mRNA degradation
(11–14).
MiR-122 is transcribed from a single locus and is
conserved among vertebrates (15). It is highly and select-
ively expressed in liver where it regulates lipid metabolism
(16). In addition to its natural function, miR-122 plays
a pivotal role in the in the life cycle of the liver-tropic
hepatitis C virus (HCV) (17,18). MiRNAs can be inhibited
from binding their targets by complementary oligonucleo-
tides (antimiRs) (19). MiR-122 was ﬁrst inhibited in
cultured cells using a complementary 20-O-methyl RNA
(20-O-Me RNA) (20), and in mice using
phosphorothioated, and cholesterol-linked-20-O-Me
RNA (16). Since then, a wide array of modiﬁed
antimiRs has been investigated, the most prominent of
which is a mixed locked nucleic acid (LNA)/DNA
phosphorothioated sequence SPC3649. SPC3649 has
been tested in mice (21,22), African green monkeys (22),
as well as chimpanzee models of HCV infection (23). In
mid-stage clinical trials, SPC3649 (miravirsen) potently
suppresses viral load when administered to HCV
patients (24).
As our knowledge of miRNA biogenesis grows,
miRNA precursors are increasingly appreciated as func-
tional RNAs with their own regulatory elements (25).
Responding to a need for chemical tools to investigate
the individual steps of biogenesis, we launched a
program to characterize ligands binding selectively to
miRNA precursors. Such ligands may eventually ﬁnd
use as antagonists in therapeutic applications where the
new synthesis of miRNAs is limiting. We have established
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a variety of novel assays to characterize miR-122 precur-
sor/ligand interactions including a minimalistic Dicer
enzymatic assay, a surface plasmon resonance (SPR)
binding assay to quantify binding kinetics and a cellular
reporter assay for Microprocessor cleavage of pri-
miRNAs. In the course of this work, we discovered that
SPC3649, the active component of miravirsen, suppresses
the biogenesis of miR-122 at the pri- and pre-miRNA
levels. This suppression may contribute to the pharmaco-
logical activity of this candidate drug.
MATERIALS AND METHODS
Olignoucleotide sequences
See Supplementary Table S1.
HPLC-MS binding assay
Synthetic pre-miR-122 (ﬁnal concentration 0.25 mM), the
four test antimiRs (ﬁnal concentration 2.5 mM) and their
mixtures were incubated in H2O (Millipore) for 15min at
room temperature, then analyzed on a high pressure liquid
chromatography - mass spectrometer (HPLC-MS) appar-
atus (Agilent 1200/6130) ﬁtted with a C-18 reverse phase
(RP) column (Waters Acquity OST C18, 2.1 50mm,
1.7mm) equilibrated at 40C to limit denaturation of the
putative duplex. Elution conditions were MeOH (18–30%
in 10min, then up to 90% in 5min) in aqueous hexaﬂuor-
oisopropanol (HFIP) (0.4M)/triethylammonium (TEA)
(16.2mM) buffer.
HPLC-MS Dicer assay
Synthetic pre-miR-122 (ﬁnal concentration 2.5mM)
was incubated alone, with 1 unit of commercial Dicer
(T520002, Genlantis, San Diego) or with commercial
Dicer after preincubation with oligonucleotides (ﬁnal con-
centration 5 mM) in a buffered aqueous solution (Tris–HCl
30mM, MgCl2 3mM, NaCl 50mM, DTT 1mM) for 2 h
at 37C. The reactions were stopped by addition of 0.5 ml
of 0.5M EDTA (pH 8) and kept at 4C before analysis
using a C18 RP column equilibrated at 70C with detec-
tion set to 260 nm. Elution conditions were 12–25%
MeOH in aqueous HFIP (0.4M)/TEA (16.2mM) buffer
in 10min. Observed mass of miR-122-5p: 7115Da;
calculated mass: 7116Da; observed mass of
50-phosphorylated miR-122-3p: 7016Da; calculated
mass: 7017Da; observed mass of loop sequence 50-phos-
UGUCUAAACUAUCA: 4455Da; calculated mass:
4456Da; observed mass of extended miR-122-5p:
8684Da; calculated mass of 50-OH miR-122-5p elongated
by 5 nt: 8685Da.
Cell cultures and transfections
HeLa and Huh-7 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) GlutaMAXTM-I
(31966-021, Gibco, Life Technologies) supplemented
with 10% of fetal bovine serum. Transfections were
performed according to the manufacturer’s protocol
with Lipofectamine 2000 (11668-019, Invitrogen, Life
Technologies, Carlsbad) for antimiRs, Oligofectamine
(12252-011, Life Technologies, Carlsbad) for pre-
miRNA and JetPEI (101-10, Polyplus transfections,
Illkirch) for plasmid DNA.
Luciferase assays
Cells were seeded in opaque white 96-well plates (136 101,
Nunc, Roskilde) in 80-ml medium per well, and transfected
according to the experimental setup with the reagents
described above. Reporter plasmids were transfected at
10 ng [Glycogen Synthase 1 (GYS1) reporter, HeLa
cells], 15 ng (Drosha reporter and control reporter, HeLa
cells; miR-122-5p sensor reporter, Huh-7 cells) or 20 ng
(miR-122-3p reporter, Huh-7 cells). The assay was per-
formed with the Dual-Glo Luciferase Assay System
(E2980, Promega, Fitchburg). The cell culture medium
was removed and 30 ml of a solution composed of
luciferase buffer with dissolved luciferase substrate and
water in a ratio of 1:1 were added to each well. After
10min, the luminescence was measured on a Mithras LB
940 plate reader (Berthold Technologies, Bad Wildbad).
Fifteen microliters of a 1% solution of stop & glo sub-
strate in stop & glo buffer were added to each well and
luminescence was again measured after 10min. Each time
luminescence was measured for 1 s per well. For each well,
Renilla luminescence counts were normalized on ﬁreﬂy lu-
minescence counts, then average values were computed.
psiCHECK-2 reporter constructs
The target sequences were either cloned from HeLa
genomic DNA (pri-miR-122 Drosha reporter) by poly-
merase chain reaction (PCR) with primers containing
suitable restriction sites in a two-step process, ampliﬁed
from synthetic DNA (miR-122-5p reporter, miR-122-3p
reporter) or produced by overlap extension PCR (26,27)
(Drosha reporter control), using oligonucleotides
(Supplementary Table S1) from Microsynth (Balgach)
and Finnzymes Phusion High Fidelity DNA Polymerase
(F530-S, Finnzymes, Vantaa).
After ampliﬁcation, the samples were analyzed by
agarose gel electrophoresis (1.5%) in a ﬁeld of 100V for
1 h. The PCR reactions corresponding to bands of the
correct size on the gel were puriﬁed, digested and ligated
into the previously digested and dephosphorylated
psiCHECK-2 plasmid (C8021, Promega, Fitchburg).
The ligated fragment was transformed into Subcloning
EfﬁciencyTM DH5aTM Competent Escherichia coli
(18265-017, Life technologies, Carlsbad), plated on LB
agar with 100 mg/ml Amp and incubated for at least 16 h
at 37C. The single colonies (or in the case of a ﬂorid
growth, pools of colonies) were picked and resuspended
in water. An aliquot of the suspension was cracked by
heating to 95C for 15min and analyzed by PCR using
two primers designed to anneal at 50 bp from the restric-
tion sites of psiCHECK-2 vector using an annealing tem-
perature of 64C. Aliquots of clones yielding positive
bands were used to make glycerol stocks and DNA
minipreps and were sequenced by Microsynth (Balgach).
All the PCR puriﬁcations were performed following the
protocol of MinElute PCR Puriﬁcation Kit (250) (28006,
Qiagen, Venlo). Miniprep were performed following the
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protocol of QIAprep Spin Miniprep Kit (250) (27106,
Qiagen, Venlo). Digestions were performed following the
guideline of the NEB Web site (http://www.neb.com)
using NotI and XhoI according to the supplied protocol
(NEB, Ipswich). The ligations were performed with
ratios of 1:3, 1:5, 1:10 (vector to insert) using the
dephosphorylated psiCHECK-2 vector with T4 DNA
Ligase (M1804, Promega, Fitchburg).
qRT-PCR
Except for the experiments with murine primary hepato-
cytes, total RNA was extracted using the RNeasy
kit (74104, Qiagen, Venlo). TaqMan quantitative
reverse transcription (RT) PCR (qRT-PCR) was per-
formed using standard reagents from Applied
Biosystems (TaqMan MicroRNA Assays: miR-122-5p:
002245; miR-122-3p: 002130; miR-16-5p: 000391; miR-
191-5p: 002299). The pre-miR-122 TaqMan probe was
made by Applied Biosystems with the pre-miR-122
sequence used as input in the online custom TaqMan
small RNA assay design tool (4398987). The RT was per-
formed using the TaqMan primers from MicroRNA
Assays and the TaqMan MicroRNA Reverse
Transcription Kit (4366596, Life Technologies,
Carlsbad) with 25 ng of total RNA. The PCR was per-
formed in a LightCycler 480 instrument (Roche,
Penzberg) with TaqMan Unversal PCR Master Mix.
No AmpErase UNG (4324020, Invitrogen, Life
Technologies, Carlsbad) according to the manufacturer’s
protocol. Each reaction was carried out in four technical
replicates. Ct values were calculated for each and
averaged.
SYBR Green qRT-PCR was performed with total RNA
extracted in the same way as above. RT was performed
with M-MLV Reverse Transcriptase, RNase H Minus,
Point Mutant (M3681, Promega, Fitchburg) and equal
amounts of oligo-dT (C1101, Promega, Fitchburg) and
random hexamer primers (SO142, Thermo Scientiﬁc,
Waltham). SYBR Green PCR was performed in a
LightCycler 480 instrument (Roche, Penzberg) with
FastStart Universal SYBR Green Master (Rox)
(04913914001, Roche, Penzberg). Each reaction was
carried out in three technical replicates. Ct values were
calculated for each and averaged.
SPR measurements
The SPR measurements of SPC3649, AMO-122 and
controls against the hairpin of pre-miR-122 were per-
formed using a SPR2 machine (Sierra Sensors GmbH,
Hamburg, Germany). The measurements were performed
at ﬂow rates of 25 ml/min at 25C, and 37C, respectively.
For the analysis, a matrix-free carboxymethylated amine
chip (C1 type) was used. During the immobilization
process, a phosphate buffered saline (PBS) buffer
(200mg/l KCl, 200mg/l KH2PO4, 8 g/l NaCl and 1.15 g/l
Na2HPO4, 0.05% TWEEN20, pH 7.4) was used at a ﬂow
rate of 25 ml/min. The chip was activated by the injection
of 150 ml of a EDC/NHS solution (containing 50mM
N-hydroxysuccinimide and 200mM 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (Sierra
Sensors) in desalted, sterile water) at a ﬂow rate of 25 ml/
min at 37C (this yields high immobilization levels). After
activation, the chip was coated with Streptavidin (Jackson
ImmunoResearch Laboratories, Inc., PA, USA). For the
analysis, we used two different chips of the same chemis-
try. The immobilizations were done with injections of
100 mg/ml streptavidin in NaAc, 10mM, pH 5.5 (170 ml,
25 ml/min), over both ﬂow cells yielding 1850 RU for both
chips. Subsequent injection of 100ml of a 1M
ethanolamine/NaOH solution, pH 8.5, was used for
blocking of unreacted sites. For the interaction analysis,
ﬂow cell 1 was left unreacted (containing only
streptavidin) and served as reference cell. After changing
to a Tris-buffer (trishydroxymethylaminomethane 20mM,
MgCl2.6H2O 5mM, CaCl2.6H2O 2mM, KCl 2mM, NaCl
140mM and TWEEN 20 0.05% in sterile, desalted and
rigorously degassed water), the biotinylated ligands (pre-
miR-122) were bound onto ﬂow cell 2 of the streptavidin-
coated surface: 110 RU for the ﬁrst chip (30 nM solution
of biotinylated ligand, 100 ml at 25 ml/min, Tris-buffer) and
165 RU for the second chip (same conditions). The
sensorgrams of the analytes were obtained by injections
of 300 ml of 342 nM solutions with two-fold dilutions in
Tris-buffer followed by a dissociation time of 330 s. As a
regeneration solution, we used a 1:1:1 mixture of water, an
acid regeneration solution (equal volumes of oxalic acid,
H3PO4, formic acid and malonic acid, each at 0.15M,
mixed and adjusted to pH 3.0 with HCl) and an ionic
regeneration solution [KSCN (0.46M), MgCl2 (1.83M),
urea (0.92M) and guanidine HCl (1.83M)]. The pH-
value of this solution was 2. The ﬁtting of the
sensorgrams was performed using Scrubber2.0 (BioLogic
Software, http://www.biologic.com.au) using a 1:1
binding model with accounting for mass-transport
limitation.
Primary hepatocytes isolation and transfection
Eight- to twelve-week-old male C57BL/6 mice were
anesthetized by intraperitoneal injection of 150 ml of
pentobarbital (Esconarkon US vet) prediluted 1:5 in
PBS. The liver was perfused by cannulation of the
caudal vena cava with the portal vein as a drain. The
liver was perfused with prewarmed Hank’s Balanced Salt
Solution (14175-053, Invitrogen, Life Technologies,
Carlsbad) containing 0.5mM ethylene glycol tetraacetic
acid (EGTA) followed by digestion of the extracellular
matrix with prewarmed digestion media [DMEM, 1 g/l
glucose (31885-049, Invitrogen,), 1% Penicillin-
Streptomycin (Invitrogen, 15140-122), 15mM HEPES
(Invitrogen, 15630-056, Life Technologies, Carlsbad) and
30 mg/ml Liberase (05401119001, Roche, Penzberg)] each
for 4min at a ﬂow rate of 5ml per min. The liver was
surgically removed, hepatocytes released into 5ml diges-
tion media by shaking and supplemented with 20ml ice
cold low glucose media [DMEM, 1 g/l glucose (31885-049,
Invitrogen, Life Technologies, Carlsbad), 1% Penicillin-
Streptomycin (15140-122, Invitrogen, Life Technologies,
Carlsbad), 10% (v/v) fetal bovine serum (F7524, Sigma,
St. Louis) and 1% Glutamax (35050, Invitrogen, Life
Technologies, Carlsbad)] and ﬁltered through a 100 mm
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Cell Strainer (352360, BD, Franklin Lakes). The suspen-
sion was then washed three times with 25ml of ice cold
low glucose media (50 g at 4C for 2min). Hepatocytes
were counted and plated at 300 000 cells/well in precoated
six-well plates (353846, BD Franklin Lakes) in low glucose
media and incubated at 37C in a humidiﬁed atmosphere
containing 5% CO2. Four hours after plating, cells were
transfected using Dharmafect1 (T-2001-03, Thermo
Scientiﬁc, Waltham) using the manufacturer’s instruc-
tions. The transfection was performed in Hepatozyme
media [HepatoZYME-SFM (17705-021, Invitrogen, Life
Technologies, Carlsbad) containing 1% Penicillin-
Streptomycin (15140-122, Invitrogen, Life Technologies,
Carlsbad), 1% Glutamax (35050-061, Invitrogen, Life
Technologies, Carlsbad)] with 5 ml of Dharmafect1/well
and an end volume of 1.25ml. Twenty-four hours after
transfection, the media was changed to 2ml Hepatozyme
media per well. At the end, the cells were washed twice
with ice cold PBS, 1ml of Trizol reagent (15596-018,
Invitrogen, Life Technologies, Carlsbad) was added and
frozen at 80C for later RNA extraction. RNA was
extracted using the Trizol according to manufacturer’s
instructions, except for the isopropanol precipitation of
RNA, which was done for half an hour at 20C.
RESULTS
Synthesis of pre-miRNAs
Pre-miRNAs can be prepared by in vitro transcription from
DNA templates or by solid-phase synthesis. They are typ-
ically 50–90 nt in length, which likely represents the upper
limit for chemical synthesis using conventional reagents.
Pre-miR-122 is 58 nt long and carries a 2 nt overhang at
the 30-terminus (www.mirbase.org). We synthesized pre-
miR-122 with terminal 50- and 30-OH groups for solution
phase binding assays and cell assays. It was puriﬁed by RP-
HPLC (see Figure 1a) and was characterized by mass spec-
trometry (MS). For immobilization of pre-miR-122 for
SPR studies, we extended pre-miR-122 with a 30-oligo-dT
bearing a terminal biotin moiety.
SPC3649 inhibits Dicer processing of pre-miR-122 in vitro
We have optimized an enzymatic assay to characterize
ligands that will modulate the Dicer processing of pre-
miRNAs. The assay uses HPLC to separate substrates
and products, and coupled MS to determine their mass
and their identity. Previous accounts of Dicer assays typ-
ically used lysates or immunoprecipitated Dicer. Our
assay uses a commercially available Dicer, which is report-
edly optimized for the production of short interfering
RNAs from double-stranded RNA. It has previously
been used together with a ﬂuorescently labeled blunt-
ended pre-miRNA analog (28,29). Use of the authentic
pre-miRNA in our assay ensured processing to the bona
ﬁde miR-122-5p- and 3p- strands, thus simulating closely
Dicer processing of pre-miR-122 in the cell.
Incubation of pre-miR-122 with Dicer resulted in its
cleavage into well-separated products, which were unam-
biguously identiﬁed by mass as the miR-122-5p and the
50-phosphorylated miR-122-3p miRNAs. These were
sequence-identical with the most abundant miRNAs
from hsa-mir-122 registered in miRBase and from deep-
sequencing, respectively (30) (Figure 1b). The
50-phosphorylated 14-nt apical loop of pre-miR-122 was
also identiﬁed. Although the efﬁciency and precision of
the cleavage varied with batches of the enzyme, these
three products were consistently among the most
abundant. Taken together, the experiments showed that
this enzyme recognizes and cleaves chemically synthesized
pre-miR-122 in vitro into the correct products under the
chosen conditions, in the absence of cofactors or protein
binding partners such as TAR (HIV-1) RNA binding
protein 1 (TRBP) (31).
During optimization of this assay we tested four
antimiRs (Supplementary Table S1): SPC3649
(miravirsen), a 15-nt LNA/DNA phosphorothioate
sequence complementary to nt 2–16 of miR-122-5p;
SPCcon, identical in sequence to SPC3649 except for
two mismatched nt in the center and close to the
terminus (21); AMO-122, a previously described (16), par-
tially phosphorothioated 2’-O-Me RNA antimiR fully
complementary to miR-122-5p; AMOcon: a scrambled
sequence of AMO-122 bearing no signiﬁcant complemen-
tarity to pre-miR-122. These controls were intended to
guide optimization of assay parameters (concentrations,
time points, buffers, etc.), as well as to indicate any
nonspeciﬁc inhibition of Dicer. Incubation of pre-miR-
122 with SPCcon (Figure 1c) or AMOcon (Figure 1d)
did not affect signiﬁcantly its processing by Dicer. For
both oligonucleotides the amounts of 5p and 3p
products were comparable with those seen in the control
reaction (Figure 1b). In contrast, SPC3649 (Figure 1e)
slowed the reaction signiﬁcantly, decreasing the yields of
miRNAs to barely detectable levels. Surprisingly, AMO-
122 also appeared to inhibit the course of the processing
by shifting the cleavage event into the loop region of the
hairpin (Figure 1f). A single dominant product was visible
in the chromatogram, and mass analysis suggested that it
was an elongated miR-122-5p strand. In summary, both of
the antimiRs affected Dicer processing of pre-miR-122,
whereas the noncomplementary control sequences did
not. This implied that SPC3649 and AMO-122 invade
the stem of pre-miR-122 by binding to the 5p-strand
and preventing correct and efﬁcient cleavage by Dicer.
In the case of the former, Dicer processing was halted;
for the latter, AMO-122 may have acted as a surrogate
passenger strand (32), shifting the cleavage to produce an
extended miRNA.
SPC3649 invades the hairpin structure of pre-miR-122
Invasion of structured RNAs by oligonucleotides to
induce misfolding of the RNA has been described
earlier. For example, short LNA oligonucleotides
induced misfolding of group I introns from rRNA genes
in pathogenic organisms and inhibited self-splicing (33);
similarly, LNAs were used to inhibit the RNA component
of telomerase (34). In the miRNA ﬁeld, morpholino-
modiﬁed oligonucleotides were shown to inhibit biogen-
esis of zebra ﬁsh miRNAs (35).
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We used two assays to demonstrate that SPC3649
invades the pre-miR-122 hairpin consistent with its inhib-
ition of Dicer processing. In one, incubation of SPCcon or
AMOcon separately with pre-miR-122 and injection into
an HPLC column showed distinct separated peaks
of oligoribonucleotides in the MS chromatograms
(Figures 2a and b, respectively). In contrast, a short incu-
bation of SPC3649 with pre-miR-122 gave attenuation
of both components and the appearance of a sharp new
slower-running peak containing the masses of both
pre-miR-122 and SPC3649, consistent with an RNA
hybrid structure comprising SPC3649 and pre-miR-122
(Figure 2c). Incubation of pre-miR-122 with AMO-122
showed no new slower-running peaks, but did result in
some broadening of the pre-miR-122 peak (Figure 2d),
possibly indicating a dynamic equilibrium between
species with different binding afﬁnities to the column.
To quantify the afﬁnity of SPC3649 for pre-miR-122,
we used SPR spectroscopy. SPR is an established tech-
nique for the precise measurement of afﬁnities and
kinetics of intermolecular interactions (36). It is
commonly used to characterize interactions involving
proteins, but its use with folded RNAs is growing
(37,38). Pre-miR-122 and mature miR-122-5p-strand (as
control) were each synthesized with an extended
biotinylated 30-dT6 spacer group for binding to the
streptavidin surface of an SPR chip. We then determined
the KD of SPC3649 for the surface-bound pre-miR-122 as
well as for single-stranded mature miR-122-5p from
sensorgrams generated under a range of conditions. For
SPC3649, we identiﬁed one binding site on pre-miR-122 at
25 (Figure 2e) and 37C from which we calculated KDs of
22 and 62 nM, respectively. No measurable binding was
observed for either SPCcon or AMOcon to pre-miR-122
under these conditions (Figures 2f, 2g, resp.). We also at-
tempted to quantify the interaction of the antimiRs with
mature miR-122-5p. Under similar experimental condi-
tions, we observed a rapid and irreversible association of
SPC3649 with miR-122-5p (Supplementary Figure S1). As
no dissociation of the duplex was seen on switching to a
buffer wash, we were unable to calculate a KD for this
irreversible binding, consistent with the expected higher
afﬁnity of the antimiR for the unstructured mature
miRNA compared with the hairpin. The 23 nt 2’-O-Me
RNA AMO-122 also associated equally strongly with
pre-miR-122 (KD 18 nM) (Figure 2h), in accordance with
its modulation of pre-miR-122 processing by Dicer
(Figure 1f). Furthermore, the rate of dissociation (kd) of
AMO-122 was 5-fold slower than that of SPC3649, sug-
gesting that once in place the longer duplex formed by
AMO-122 has an extended half-life, and may be more
difﬁcult to displace by the dangling 3p strand of the pre-
miRNA. The combined data from these in vitro experi-
ments suggested that SPC3649 might invade the stem
structure of both pri- and pre-miR-122 precursors in vivo
and disrupt their processing to mature miRNAs.
SPC3649 inhibits biogenesis of miR-122 in cells
We investigated the ability of SPC3649 to interfere with
the individual steps of miR-122 biogenesis using combin-
ations of oligonucleotides and luciferase reporter con-
structs in HeLa cells, which do not express miR-122
(20), in Huh-7 cells expressing moderate levels of endogen-
ous miR-122-5p (15) and in highly expressing primary
hepatocytes (15). Both of the precursors of miR-122
contain the same hairpin secondary structure. However,
pre-miR-122 is typically present at much lower levels in
cells compared with pri-miRNAs or mature miRNAs (39).
Therefore, we examined the capacity of SPC3649 to
inhibit Dicer processing of synthetic pre-miR-122
delivered exogenously into HeLa cells.
We ﬁrst conﬁrmed that pre-miR-122 is efﬁciently trans-
fected into HeLa cells and is processed by endogenous
Dicer. Consistent with the data shown in Figure 1b, we
detected a dose-dependent production of miR-122-5p
(Figure 3a) demonstrating that endogenous Dicer recog-
nizes the synthetic pre-miR-122. To conﬁrm that this miR-
122-5p was functional, we cotransfected the RNA hairpin
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Figure 1. SPC3649 inhibits Dicer processing of pre-miR-122 in vitro. AntimiRs (5mM) were added to synthetic pre-miR-122 in buffer (2.5 mM) before
addition of Dicer. Reactions were quenched after 2 h and analyzed by HPLC-MS. (a) Pre-miR-122 alone is stable in buffer. (b) Dicer cleaves pre-
miR-122 into miR-122-5p, miR-122-3p and the loop. SPCcon (c) and AMOcon (d) do not affect processing, whereas SPC3649 (e) inhibits processing.
(f) AMO-122 shifts the cleavage site to yield miR-122-5p elongated by 5 nt.
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with a dual reporter plasmid expressing Renilla and ﬁreﬂy
luciferase. A previously characterized binding site for
miR-122-5p from the GYS1 30-UTR (40) was inserted
into the 30-UTR of the Renilla mRNA, whereas the
ﬁreﬂy luciferase was used to normalize for differences in
transfection efﬁciency of the plasmid. Dose-dependent
downregulation of Renilla luciferase activity was
observed consistent with suppression of the 30-UTR by
the 5p strand: a control short interfering RNA had no
effect (Figure 3b). When the experiment was performed
in the presence of SPC3649 or AMO-122, a dose-depend-
ent derepression of Renilla luciferase activity was observed
(Figure 3c). SPCcon showed a greatly reduced effect, but
some inhibition at the highest dose consistent with
previous observations that two mismatches in the
sequence of a high afﬁnity antimiR would not necessarily
remove all of its inhibitory activity (32). AMOcon—a
scrambled sequence—showed no signiﬁcant effect. This
assay does not distinguish, as the source of derepression
of luciferase activity, the inhibition of Dicer processing of
pre-miR-122 from a sequestration of the mature miR-122-
5p. Measuring the abundance of mature miR-122 by PCR
or northern blot could theoretically differentiate between
these two mechanisms as inhibition of Dicer would result
in decreased mature miRNA. However, both of these
methods are reportedly prone to artifacts caused by the
presence and interference of the antimiR in samples with
the assayed miR-122-5p (16,41). Therefore, we asked
instead whether the antimiR treatment of cells processing
synthetic pre-miR-122 would show an accumulation of
pre-miR-122 levels in line with a strand invasion of the
hairpin and a disruption of Dicer activity. For this we
used PCR primers speciﬁc for the precursor rather than
the mature miRNAs. To conﬁrm correct functioning of
the PCR assay, pre-miR-122 was transfected alone into
HeLa cells, and after 24 h, RNA was isolated: intact pre-
miR-122 was detected in treated but not untreated control
cells (Figure 3d, right panel). Next, in a double transfec-
tion experiment, cells were treated ﬁrst with SPC3649,
SPCcon or AMOcon, followed by transfection with pre-
miR-122 (Figure 3d, left panel). After 24 h, AMOcon
treatment showed intact pre-miR-122, albeit at higher
levels than observed in the single transfection
(Figure 3d, right panel): this might have been due to
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Figure 2. SPC3649 binds pre-miR-122 with nanomolar afﬁnity in vitro. Overlaid HPLC-MS chromatograms of synthetic pre-miR-122 (0.25 mM)
incubated with antimiRs (2.5mM) in water: pre-miR-122 alone produces a single peak (top trace); antimiRs were analyzed alone (center traces) and
then mixed with pre-miR-122 hairpin in solution and injected (lower traces). No effects on the peak of pre-miR-122 were observed on incubation
with (a) SPCcon or (b) AMOcon. (c) The addition of SPC3649 resulted in loss of pre-miR-122 and the appearance of a new peak, containing both
SPC3649 and pre-miR-122. (d) Addition of AMO-122 to pre-miR-122 resulted in a broadening of the pre-miR-122 peak. SPR sensorgrams of
antimiRs bound to immobilized pre-miR-122 at four concentrations (342 nM; 2-fold dilutions) and 25C: each trace represents a different concen-
tration of antimiR; the highest binding (Response) is seen with higher concentrations of antimiR; the arrow indicates a switch to running buffer and
the beginning of the dissociation phase: (e) SPC3649 binds concentration dependently to pre-miR-122 with calculated KD of 22 nM: ka was
17000M1s1, and kd was 3.8 104 s1. (f) SPCcon and (g) AMOcon show no association with pre-miR-122. (h) AMO-122 binds concentration
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sequence-unspeciﬁc effects or a negative inﬂuence of the
second transfection on processing. SPCcon showed a
similar level of intact pre-miR-122 as AMOcon
(Figure 3d, left panel). However, the highest accumulation
of pre-miR-122 was seen from treatment with SPC3649,
consistent with inhibited processing of exogenously
delivered pre-miR-122 by the SPC3649 and in agreement
with experiments performed in vitro (Figures 1 and 2).
In liver cells, pre-miR-122 is expressed at 400-fold lower
levels than mature miR-122 (39). Therefore, we turned to
the potential effects of SPC3649 on the Drosha processing
of endogenous pri-miR-122 in the nucleus of Huh-7 cells:
single-stranded oligonucleotides are active in the nucleus
after transfection. We transfected Huh-7 cells separately
with the four antimiRs and then studied residual endogen-
ous pri-miR-122 levels using qRT-PCR. A signiﬁcant
accumulation of pri-miR-122 at 72 h after transfection
was seen for treatment with SPC3649, but not for
AMO-122 or the negative controls (Figure 4a). This
result would be consistent with invasion of pri-miR-122
by SPC3649, and the inhibition of Drosha processing in
the nucleus. To exclude that the accumulation of endogen-
ous pri-miR-122 was not solely due an indirect effect, for
example, from enhanced transcription of the gene, we de-
veloped a Drosha reporter assay similar to one recently
described (42). A sequence containing the pri-miR-122
hairpin was cloned into the 30-UTR of Renilla luciferase
in a standard psiCHECK-2 dual luciferase vector. We
anticipated that the corresponding reporter mRNA
would fold into the same hairpin structure as in the pri-
miRNA (Figure 4b) and therefore would be recognized
and processed by the Microprocessor; we have shown pre-
viously that artiﬁcially constructed fusion mRNAs usually
maintain their local folding structures (43). Thus, Drosha
was expected to excise pre-miR-122 from this UTR, and in
so doing would cleave the polyA tail of the reporter
mRNA, subjecting it to degradation by 30-exonucleases
with a concomitant loss of Renilla activity. In parallel, a
control vector comprising the same pri-miR-122 insert,
but lacking the 3p-strand of the stem-loop was also con-
structed. The mRNA produced from this construct was
not expected to be a substrate for Drosha, and therefore
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Figure 3. Inhibition of Dicer processing of pre-miR-122 by SPC3649 and AMO-122 (a) HeLa cells were treated with synthetic pre-miR-122 (0, 2.5,
5, 10 nM). RNA was extracted 24 h later and analyzed by qPCR. The threshold cycle (Ct) values were normalized to miR-191-5p and transformed to
generate relative abundance values. Error bars are SEM of four qPCR replicates. (b) Synthetic pre-miR-122 (0, 2.5, 5, 10 nM) silences GYS1 30-UTR
luciferase reporter in HeLa cells dose dependently. Renilla and ﬁreﬂy luciferase luminescence were measured after 72 h, and Renilla activity was
normalized to that of ﬁreﬂy. Error bars are SD of three transfections. Data were analyzed by ANOVA using Dunnett’s post-test in Graphpad Prism
6, comparing against the lowest dose in each group (*P< 0.05, **P< 0.01, ***P< 0.001). (c) AntimiRs inhibit miR-122–mediated suppression of
GYS1 30-UTR reporter. Cells were transfected with reporter plasmid and treated with antimiRs (0.6, 2.5, 10, 40 nM), before transfection with pre-
miR-122 (10 nM). Normalized Renilla activity was determined as in (b). Data were analyzed by ANOVA using Dunnett’s post-test in Graphpad
Prism 6, comparing against the lowest dose in each group (**P< 0.01, ***P< 0.001). (d) SPC3649 accumulates intact synthetic pre-miR-122 in HeLa
cells. Cells were transfected with 50 nM SPC3649, SPCcon or AMOcon, respectively, and 6 h later, 10 nM pre-miR-122 (left panel); cells were
transfected with 10 nM pre-miR-122 alone or left untreated (right panel). After 24 h, qPCR was performed for pre-miR-122 and miR-191 expression.
Ct values were calculated and transformed into relative abundance, using miR-191 as internal standard and normalizing on SPCcon. Error bars are
SEM of four qPCR replicates. P-values were calculated using the two-tailed unpaired Student’s t-test with equal variances in Graphpad Prism 6
(*P< 0.05, **P< 0.01, ***P< 0.001).
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Figure 4. SPC3649 inhibits Microprocessor-mediated processing of pri-miR-122. (a) Huh-7 cells were transfected with antimiRs (40 nM). RNA was
isolated after 48 h and 72 h. qPCR was performed for expression of pri-miR-122 and for SF3A1 mRNA (housekeeping gene). Ct values were
calculated and transformed into relative abundance. Error bars indicate SEM of three qPCR replicates. P-values were calculated using the two-
tailed unpaired Student’s t-test with equal variances in Graphpad Prism 6 (*P< 0.05). (b) Principal function of a Drosha reporter mRNA and its
control. The pri-miR-122 stem-loop and 100 nt ﬂanking sequence were cloned into the 30-UTR of the Renilla luciferase in the psiCHECK-2 reporter
plasmid (left). The expressed mRNA forms a stem-loop, which is recognized by the Microprocessor and is processed to miR-122. The control
plasmid (right) expresses an mRNA that lacks the 3p sequence of the pri-miR-122. (c) Plasmids from (b) were transfected separately into HeLa cells.
Levels of ﬁreﬂy and Renilla activity were measured after 24 h. Error bars are SD of 12 transfections. P-values were calculated using the two-tailed
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should not undergo cleavage-mediated degradation. We
ﬁrst compared the two reporters by measuring their
ﬁreﬂy and Renilla luminescence counts after transfection
of equal amounts into HeLa cells. As expected, the ﬁreﬂy
luciferase counts from both reporters were comparable.
However, the Renilla counts from the Drosha reporter
were a fraction of those of the control vector, consistent
with degradation of Renilla mRNA (Figure 4c). To
conﬁrm the processing of this mRNA by Drosha, we
assayed for the presence of mature miR-122 miRNAs
using qRT-PCR. After 24, 48 and 72 h, clearly detectable
levels of miR-122-5p were present (Figure 4d), consistent
with a correct excision and processing of miR-122 from
the reporter 30-UTR by both Drosha and Dicer. We then
cotransfected the antimiRs with the Drosha reporter
plasmid into HeLa cells and measured Renilla luciferase
levels. A clear dose-dependent derepression effect was
observed in the case of SPC3649, with possibly a small
effect from the AMO-122. In contrast, neither of the
negative controls showed signiﬁcant activity (Figure 4e).
These observations are consistent with a sequence-speciﬁc
inhibition of Drosha processing of the pri-miR-122
reporter by SPC3649, in accordance with strand invasion
of the hairpin structure.
As explained above, we did not try to distinguish
between inhibition of miR-122 biogenesis and sequestra-
tion of mature miR-122-5p by antimiRs by assaying the
functional activity of endogenous miR-122-5p. However,
an inhibition of pri-miRNA processing will not only
suppress new synthesis of the mature 5p strand, but also
any 3p miRNA. MiR-122-3p has been detected in Huh-7
by sequencing although counts were low (30) and we were
unable to quantify it reproducibly in experiments using
qPCR. Nevertheless, we attempted to examine the effects
of the antimiRs on the activity of endogenous miR-122-3p
using a highly sensitive miR-122-3p luciferase reporter
containing a fully complementary target sequence to
miR-122-3p. The reporter and SPC3649 were cotrans-
fected into Huh-7 cells. After 3 days, we detected a
small but signiﬁcant derepression of Renilla luminescence
by SPC3649, with possibly some effect from AMO-122,
but no effects from the negative controls (Figure 4f). As
SPC3649 and AMO-122 have no signiﬁcant complemen-
tarity to miR-122-3p, these results support the notion that
SPC3649 and possibly AMO-122 invade the stem struc-
ture of pri-miR-122 precursor in the nucleus and suppress
the Drosha-mediated production of the 3p mature
miRNA.
In clinical trials, patients with HCV infections are
treated subcutaneously with miravirsen (SPC3649),
which accumulates in liver and sequesters mature miR-
122. Liver hepatocytes express high levels of miR-122.
Murine pre-miR-122 is highly homologous to its human
ortholog: the sequences of the 5p strands are identical and
the murine 3p strand is shorter by 3 nt. Freshly prepared
primary murine hepatocytes were treated separately with
two doses of SPC3649 and SPCcon. Isolation of RNA and
measurement of pri-miR-122 levels on three successive
days showed signiﬁcantly higher levels (2- to 3-fold) of
pri-miR-122 after the SPC3649 treatment compared with
SPCcon (Figure 4g). This contrasts with the data obtained
from Huh-7 cells in which an accumulation was only seen
on day 3 (Figure 4a). The data suggest that inhibition of
miR-122 biogenesis in the nucleus and the cytoplasm of
liver hepatocytes occurs and hence may contribute to the
clinical activity of miravirsen.
Taken together, we have shown that SPC3649 binds to
the stem-loop structures of pri- and pre-miR-122 and
inhibits miR-122 biogenesis. However, it is not known if
and by how much inhibition of miR-122 processing con-
tributes to the pharmacological activity of miravirsen. We
therefore investigated additional oligonucleotides comple-
mentary to other regions of the miR-122 hairpin to
consider the properties of SPC3649 in a wider context.
Two 15-nt LNA/DNA chimera sequences were acquired
(Figure 5a): LNA-8-15, which overlaps with SPC3649
and is complementary to the 30-end of miR-122-5p, and
LNA-41-15, which is complementary to the 30-end of miR-
122-3p.
First, we assayed all the antimiRs against a luciferase
reporter sensor bearing a fully complementary target site
to miR-122-5p in miR-122-expressing Huh-7 cells. This
assay shows the consequences of inhibiting mature miR-
122-5p, as well as the processing of endogenous pri- and
pre-miR-122. As expected, the miR-122-5p antimiRs
(SPC3649, LNA-8-15, AMO122) showed a strong concen-
tration-dependent derepression of luciferase activity, with
the greatest effect from SPC3649 (Figure 5b). LNA-41-15,
which was inactive against an unrelated control reporter
(data not shown), was also active against the miR-122-5p
sensor. It showed 20% of the activity of SPC3649 at the
two highest concentrations. As LNA-41-15 is complemen-
tary to the 3p arm of miR-122, this outcome was consist-
ent with inhibition of pri- and/or pre-miR-122 processing.
We consolidated these observations by examining the
effects of the antimiRs on aldolase A, fructose-
bisphosphate (ALDOA) (16) and GYS1 (40), two
Figure 4. Continued
unpaired Student’s t-test with equal variances in Graphpad Prism 6 (***P< 0.001). (d) HeLa cells were transfected with 200 ng of pri-miR-122
Drosha reporter. RNA was isolated after 24, 48 and 72 h, respectively. qPCR was performed for miR-122-5p, miR-122-3p, miR-16 and miR-191.
MiR-191 was used for normalization. Error bars are SEM of four qPCR replicates. (e) SPC3649 inhibits Drosha processing of a pri-miR-122
reporter in HeLa cells. Cells were transfected with the Drosha reporter and after 6 h, antimiRs (6.25, 12.5, 25, 50 nM). Renilla and ﬁreﬂy luciferase
were assayed after further 36 h. Error bars are SD of four transfections. Data were analyzed by ANOVA using Dunnett’s post-test in Graphpad
Prism 6, comparing against the lowest dose in each group (*P< 0.05, ***P< 0.001). (f) Huh-7 cells were transfected with antimiRs (0.6, 2.5, 10 nM).
After 3 days, a psiCHECK-2 miR-122-3p sensor reporter was transfected. Renilla and ﬁreﬂy activity were assayed 24 h later. Error bars indicate SD
of three transfections. Data were analyzed by ANOVA using Dunnett’s post-test in Graphpad Prism 6, comparing against the lowest dose in each
group (*P< 0.05). (g) Primary hepatocytes were extracted from a mouse, cultured and transfected with SPC3649 and SPCcon (50 nM). RNA was
isolated after 24, 48 and 72 h. qPCR (SYBR Green) was performed for the pri-miR-122 sequence, using 36B mRNA for normalization. Error bars
are SEM of three qPCR replicates. P-values were calculated using the two-tailed unpaired Student’s t-test with equal variances in Graphpad Prism 6
(*P< 0.001).
Nucleic Acids Research, 2014, Vol. 42, No. 1 617
SPR - LNA-41-15 binding to immobilized pre-miR-122
re
la
tiv
e 
ab
un
da
nc
e 
to
 3
6B
 m
RN
A 
a
n
d 
SP
Cc
on
re
la
tiv
e 
ab
un
da
nc
e 
to
 3
6B
 m
RN
A 
a
n
d 
SP
Cc
on
Huh-7 cells - miR-122-5p reporter sensor
HeLa cells - Drosha reporter
re
la
tiv
e 
lu
m
in
ec
en
ce
(re
nil
la/
fire
fly
)
LNA-8-15
pre-miR-122
LNA-41-15
LNA-41-15: 5'-TTaGaGtgATaaTgG-3'
LNA-8-15: 5'-CaAaCaCcAttGTcA-3'
SPC3649
SPC3649: 5'-CcAttGTcaCaCtCC-3'
LNA in upper case, DNA in lower case re
la
tiv
e 
lu
m
in
ec
en
ce
(re
nil
la/
fire
fly
)
SPC3649 SPCcon LNA-8-15 LNA-41-15 AMO-122 AMOcon
1.4
1.0
0.6
0.2
1.2
0.8
0.4
0.0
murine primary hepatocytes - qRT-PCR of ALDOA - 100 nM treatmentmurine primary hepatocytes - qRT-PCR of ALDOA - 50 nM treatment
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
1.4 
1.6 
1.8 
2 
24 h 
48 h 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
1.4 
1.6 
1.8 
2 
24 h 
48 h 
SPCcon
pre-miR-122
miR-122-5p
miR-122-3p
pre-miR-122
miR-122-5p
miR-122-3p
LNA-41-15
mAU
30
20
10
0
51-14-ANL51-8-ANLnocCPS9463CPS51-14-ANL51-8-ANLnocCPS9463CPS
mAU
30
20
10
0
4 nim01862
4 nim01862
Time
0 200 400 500 600 700100 300
R
es
po
ns
e
R
es
id
ua
l
0
1
2
Time
0 200 400 500 600 700100 300 s
s
SPC3649 SPCcon LNA-8-15 LNA-41-15 AMO-122 AMOcon
0.0
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
**
**
* *
**
**
*** ***
***
***
***
*** **
***
***
***
***
*
*
0
2
-2
(a)
(c)
(d) (e)
(f)
(b)
Figure 5. Targeting of miR-122-3p by LNA-41-15 inhibits biogenesis of miR-122. (a) Representative binding sites of the three LNA/DNA chimera
antimiRs on pre-miR-122. (b) LNA-8-15 and LNA-41-15 derepress a miR-122-5p sensor construct in cells expressing miR-122-5p. Huh-7 cells were
transfected with a miR-122-5p sensor construct based on the psiCHECK-2 reporter vector. Six hours later, the cells were transfected with increasing
concentrations (0.6, 2.5, 10, 40 nM) of antimiRs. Renilla and ﬁreﬂy luciferase were assayed after further 48 h. Error bars are SD of three transfec-
tions. Data were analyzed by ANOVA using Dunnett’s post-test in Graphpad Prism 6, comparing against the lowest dose in each group (**P< 0.01,
***P< 0.001). (c) SPC3649, LNA-8-15 and LNA 41-15 derepress ALDOA expression. Murine primary hepatocytes were cultured and transfected
with 50 nM (left) or 100 nM (right) of antimiRs. Cells were lysed after 24, 48 and 72 h, and total RNA was isolated. qPCR (SYBR Green) was
performed for the ALDOA mRNA, using 36B4 mRNA for normalization. Error bars are SEM of three transfections (50 nM experiment) or two
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natural targets of miR-122-5p in primary murine
hepatocytes. Indeed, in comparison with treatment with
SPCcon, higher levels of ALDOA mRNA were found 1
and 2 days after transfection of hepatocytes with the two
5p antimiRs (SPC3649, LNA-8-15) (Figure 5c). In
contrast, but consistent with the data from the reporter
assay, the 3 p antimiR LNA-41-15 showed activity only at
the 100 nM treatment. Similar results were obtained on
GYS1 mRNA at 100 nM (data not shown).
We reran three assays in an effort to derive additional
evidence that LNA-41-15 inhibited miR-122 biogenesis via
binding to the 3p arm of the precursors: the in vitro Dicer
assay, the SPR binding assay and the Drosha reporter
assay. Incubation of pre-miR-122 with recombinant
Dicer and SPCcon (Figure 5d, upper panel) yielded a
similar result to that shown previously (Figure 1c).
Assaying LNA-41-15 under identical conditions resulted
reproducibly in visibly less cleavage of the substrate con-
sistent with invasion of pre-miR-122 and inhibition of
Dicer (Figure 5d, lower panel). We then measured the
afﬁnity of LNA-41-15 for immobilized pre-miR-122 on
an SPR biosensor: LNA-41-15 bound strongly to pre-
miR-122 (Figure 5e): it did not bind to miR-122-5p (data
not shown). In addition, LNA-8-15 was unable to invade
pre-miR-122 under the same conditions (data not shown).
Finally, we used the Drosha reporter assay in HeLa cells to
provide insight as to whether LNA-41-15 could inhibit pro-
cessing of pri-miR-122. Consistent with the results of the
biosensor binding assays, SPC3649 and LNA-41-15 in-
hibited sequence-speciﬁcally cleavage of this reporter
mRNA, whereas LNA-8-15 showed no activity (Figure 5f).
In summary, we have shown that invasion of the hairpin
structure of miR-122 precursors by two independent
antimiRs targeting separately the 5p and 3p arms
(SPC3659 and LNA-41-15, respectively) leads to its inhib-
ition of processing by Drosha and Dicer. As LNA-41-15
does not bind to mature miR-122-5p, its inhibition of the
function of the mature miRNA (miR-122-5p) (Figure 5b
and c) likely derives from inhibition of the precursors.
Extrapolating these observations to SPC3649 it appears
likely that part of the pharmacological effects of miravirsen
is attributable to its suppression of miR-122 biogenesis, in
addition to its sequestration of mature miR-122-5p.
DISCUSSION
To date, any discussion of the mechanism of action of
miravirsen centers upon its hybridization with mature
miR-122-5p. Indeed, mature miR-122 5p is more
abundant than its precursors in hepatocytes and has a
long half-life (44). However, the target sequence of
miravirsen is also present in the stem-loop structures of
pre-miR-122 and pri-miR-122. As part of a program to
discover ligands that bind to miRNA stem-loops, we have
developed new assays that allow us to study regulation
of the individual steps of miR-122 biogenesis (45). These
include: a minimal in vitro enzymatic/HPLC-MS assay,
which gauges semiquantitatively inhibition of Dicer
cleavage of pre-miRNAs; an SPR assay to measure the
kinetics of ligand interactions with a surface-bound pre-
miRNA and a cell reporter assay to monitor
Microprocessor-mediated cleavage of pri-miRNAs. Using
these assays we discovered that SPC3649 (miravirsen)
invades the stem structure of miR-122 precursors and
inhibits Drosha and Dicer processing of pri-miR-122 and
pre-miR-122, respectively (Figure 6).
We demonstrated invasion and sequence-speciﬁc
binding of pre-miR-122 by SPC3649 in two in vitro
assays (Figure 2). This nanomolar interaction was shown
to be functional in an enzymatic assay in which the
cleavage of synthetic pre-miR-122 by Dicer was halted
by SPC3649 (Figure 1). The biophysical properties of
SPC3649 in vitro also correlated with its cellular activity.
Using exogenously delivered pre-miR-122, which was pro-
cessed into functional 5p and 3p strands in HeLa cells, we
showed that cotransfection with SPC3649 led to its
attenuated processing, causing accumulation of pre-miR-
122 (Figure 3d). Similarly, the processing of pri-miR-122
in the nucleus of Huh-7 and primary murine hepatocytes
by the Microprocessor was also inhibited by SPC3649,
leading to accumulation of endogenous pri-miR-122
(Figure 4). To show that these effects were due to inhibited
Drosha activity, we used a pri-miR-122 reporter in which
the pri-miR-122 was inserted into the 30-UTR of
luciferase. In non-miR-122-expressing HeLa cells, the
reporter mRNA was processed to mature miR-122-5p
and this was accompanied by loss of luciferase activity.
Treatment with SPC3649 led to derepression of luciferase
consistent with strand invasion of pri-miR-122 and inhib-
ition of processing (Figure 4).
Taken together, our assays demonstrated that miRNA
biogenesis can be inhibited by high-afﬁnity binding
antimiRs (Figure 6). High afﬁnity, however, is not sufﬁ-
cient for activity against miRNA precursors. SPC3649 and
AMO-122 have similar afﬁnities for pre-miR-122, yet the
considerably longer AMO-122 was less active in cell
assays. Furthermore, the slower rate of dissociation of
AMO-122 from pre-miR-122 infers a longer lifetime of
Figure 5. Continued
transfections (100 nM experiment). Data were analyzed by ANOVA using Dunnett’s post-test in Graphpad Prism 6, comparing against SPCcon for
each time point (*P< 0.05, **P< 0.01, ***P< 0.001). (d) Pre-miR-122 was incubated with SPCcon or LNA-41-15 and 1 U of recombinant com-
mercial Dicer was added. The reactions were incubated at 37C for 2 h, quenched with EDTA and analyzed by LCMS apparatus. LNA-41-15 slows
the cleavage of pre-miR-122 by Dicer compared with SPCcon by 15%. (e) SPR sensorgrams of LNA-41-15 bound to immobilized pre-miR-122 at
six concentrations (166.7 nM; 3-fold dilutions) and 25C: increased binding (response) is seen with higher concentrations of antimir; the arrow
indicates a switch to running buffer and the beginning of the dissociation phase. For LNA-41-15 a KD of 240 pm (ka 1 106M1 s1, kd
2.4 x 104 s1) was determined. The plotted residuals of the ﬁt are shown in the lower panel. (f) LNA-41-15 inhibits Drosha processing of a pri-
miR-122 reporter in HeLa cells. Cells were transfected with the Drosha reporter plasmid and after 6 h, antimiRs (6.25, 12.5, 25 nM). Renilla and
ﬁreﬂy luciferase were assayed after further 36 h. Error bars are SD of three transfections. Data were analyzed by ANOVA using Dunnett’s post-test
in Graphpad Prism 6, comparing against the lowest dose in each group (* P< 0.05, *** P< 0.001).
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the interaction (i.e. drug residence time), at least in vitro.
Consequently, the elevated activity of SPC3649 against
miR-122 precursors may partly derive from better pharma-
cokinetics, e.g. superior cellular uptake or nuclear
localization.
It is interesting to speculate whether inhibition of miR-
122 biogenesis by SPC3649/miravirsen contributes to its
pharmacological activity. Some insight on this was
provided by data from experiments with LNA-41-15, an
LNA/DNA chimera complementary to miR-122-3p. The
activity of SPC3649 derives from its binding to mature
miR-122-5p as well as its inhibition of miR-122 biogenesis.
On the other hand, LNA-41-15 selectively inhibits miR-
122 biogenesis alone, i.e. it does not bind to miR-122-5p.
In a sensitive reporter assay for miR-122-5p activity,
LNA-41-15 showed 20% of the activity of SPC3649
(Figure 5b), leading us to conclude that inhibition of
biogenesis can contribute to the overall activity of an
antimir, if it is able to invade the stem-loop structure of
the precursors. However, our experimental design does
not permit us to quantify such a contribution because
SPC3649 and LNA-41-15 are independent sequences
with their own pharmacokinetics and pharmacodynamics
properties. Thus, it cannot be assumed that they inhibit
miR-122 biogenesis to the same degree.
Today, it is accepted that regulation of several promin-
ent miRNAs is controlled at the precursor level,
for example, the LIN28/pre-let-7 interaction (46).
Concerning miR-122, its precursors (not mature miR-
122) cycle with the circadian rhythm, and one of the
models proposed to explain this phenomenon had a key
role for the precursors in regulation of circadian gene
expression (39). The importance of targeting miRNA
precursors pharmacologically awaits the development of
new classes of high-afﬁnity binding ligands.
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